ライフサイエンスコーパス: office visit

1 ht up 82.4% of topics of interest during the office visit.

2 or every 1.00 US dollars they receive for an office visit.

3 w Schedule, the Life Chart Interview, and an office visit.

4 e that was completed by patients after their office visit.

5 care team, and occurrence of a preoperative office visit.

6 d plasma testing had a blood draw during the office visit.

7 ervention and control groups at the 12-month office visit.

8 magnification was 4.32+/-1.15 at the last in-office visit.

9 measured using streak retinoscopy during an office visit.

10 by the health care provider during the same office visit.

11 billing generated 36,297 US dollars from 730 office visits.

12 facility and claims data for related patient office visits.

13 o provide anticipatory guidance at pediatric office visits.

14 associated with a reduction in the length of office visits.

15 ted to lower prices paid by private PPOs for office visits.

16 nd 1.02% (95% CI, 0.57%-1.47%) for clinician office visits.

17 nd $1.18 (95% CI, $0.66-$1.70) for clinician office visits.

18 ts, advanced imaging services, and clinician office visits.

19 d imaging services and smallest for clinical office visits.

20 tients still require numerous injections and office visits.

21 linician alerts to replace some scheduled in-office visits.

22 ons, emergency department visits, and clinic office visits.

23 sting an association with elective follow-up office visits.

24 d the nature of care they provide outside of office visits.

25 and no difference in payments for clinician office visits (0.26%; 95% CI; 0.53%-0.005%).

26 nificant increase in the per-member rates of office visits (0.7 per member per year; 95% CI, 0.6-0.7;

27 e 186 conditions seen in practice (0.74% for office visits; 0.51% for hospital stays).

28 ity by the time of their first postoperative office visit 1 week after surgery.

29 siderable health resources (median number of office visits, 11 and 7; median number of serologic test

30 were $4.8 million higher and expenditures on office visits $12.4 million higher (42% and 78% higher,

31 rson-months were 63.8 and 45.1 for physician office visits, 12.5 and 1.0 for emergency department vis

32 timated from the primary diagnosis for 13832 office visits (2010-2013 National Ambulatory Medical Car

33 ts are commonly used for clinical trials and office visits; 24- and 48-hour tests are more reliable a

34 avoid taking their children to a physician's office visit (3.8% vs. 31.6%; odds ratio, 0.07 [95% CI,

35 icians (53.1%) reported time pressure during office visits, 48.1% said their work pace was chaotic, 7

36 increase (95% CI) of 23.3% (2.04%-26.3%) in office visits, 5.8% (1.4%-10.2%) in emergency department

37 Genetic results were conveyed during an office visit (57%), by telephone (39%), or by mail (3%).

38 s brought up QPL-related topics during their office visits (70.2% v 32.6%; P < .001).

39 rom 330 antimicrobial prescriptions per 1000 office visits (95% CI, 305-355) to 234 (95% CI, 210-257;

40 ion were summarized from coaching notes; one office visit after the coaching session was audio record

41 Estimated rates of RSV-associated office visits among children under 5 years of age were t

42 Telephone interviews done after the index office visit and at 2, 4, 8, 12, and 24 weeks or until c

43 ntify high-risk individuals during a routine office visit and can be used to educate patients about m

44 dult-focused PCP visit (gap) for any type of office visit and for those that were preventive visits.

45 ld provide diagnostic information during the office visit and were compared with an acceptable criter

46 tegories of medical conditions seen in 13832 office visits and 108472 hospital stays with the percent

47 s cohort utilized a total of 5,108 physician office visits and 2,015 telephone calls.

48 ted median age at transfer of 21.8 years for office visits and 23.1 years for preventive visits and a

49 djusted median gap length of 20.5 months for office visits and 41.6 months for preventive visits.

50 Compared with standard follow-up through in-office visits and audible ICD alerts, remote monitoring

51 tients and account for a large percentage of office visits and increased medical costs.

52 on outpatient problem, resulting in frequent office visits and often requiring the use of prophylacti

53 ed to reduce the inequality between fees for office visits and payment for procedures, failed to prev

54 Between workshops, participants audiotaped office visits and studied the audiotapes.

55 l patients were followed longitudinally with office visits and telephone interviews.

56 Scheduled office visits and unscheduled evaluations, incidence of

57 screening, counseling or medications during office visits and used multiple logistic regression to a

58 oring reduces emergency department/urgent in-office visits and, in general, total healthcare use in p

59 ) completed the outcome assessment after the office visit, and 236 (76%) were followed for 6 months.

60 sulted in medication use, 27% resulted in an office visit, and 9% resulted in a referral to another p

61 gists have limited time with patients during office visits, and EHR use requires a substantial portio

62 lso had significantly more hospitalizations, office visits, and emergency department visits than both

63 cost-sharing levels for prescription drugs, office visits, and emergency department visits.

64 Higher neighborhood income level, physician office visits, and history of influenza vaccination (RR(

65 a common ailment accounting for millions of office visits annually, including that of Mrs D, a 51-ye

66 roximately 400 000 ED visits and 1.7 million office visits annually, resulting in $284 million in hea

67 ion and treatment and use general outpatient office visits as an important opportunity to prevent tob

68 onditions during their initial and follow-up office visits as were 63 thyroid control patients.

69 ces transmitted at 2-month intervals with an office visit at 6 months.

70 HM was used before office visits at 3 and 15 months in the HM group.

71 -up included 3-day Holter ECG recordings and office visits at 3, 6, and 12 months.

72 rers tend to pay for procedures, but not for office visits, at higher levels than those paid by Medic

73 who were followed per standard of care with office visits augmented by transtelephonic monitoring (C

74 sts, advanced imaging services, or clinician office visits before receiving care for that service.

75 Patients with a first office visit between 2008 and 2010 were identified and f

76 Physician office visit billing generated 36,297 US dollars from 73

77 During the study period, the office visit blood pressure measurement target was 130/8

78 nteraction that do not depend on traditional office visits, but for which there are clear incentives.

79 edical Center, UPMC) among adults seen in an office visit by a UPMC-employed primary care physician (

80 Of 333735 adult patients seen in an office visit by PCPs in 2014, 53196 patients (15.9% of t

81 ing claims, and 26.8% of 2,653,227 clinician office visit claims were associated with a prior search

82 ream revenue was generated for every 1.00 of office visit compensation applied to the academic rheuma

83 Office visits comprised approximately one half, diagnost

84 examination questions and the percentages of office visit conditions or hospital stay conditions seen

85 ever, the bariatric group's prescription and office visit costs were lower and their inpatient costs

86 to a standardized audiotape depiction of an office visit during which they heard a physician who ass

87 ia at baseline and those with fewer than two office visits during the follow-up period.

88 of beneficiaries who underwent tests and had office visits during the preceding 11 months.

89 home health care, hospital outpatient care, office visits, emergency department use, and inpatient c

90 ions on the third or fourth day of life, and office visits, emergency department visits, and hospital

91 r of days hospitalized and hospitalizations, office visits, emergency department visits, death rate,

92 ean total retail cost of prescriptions at an office visit for acne was conservatively estimated to be

93 y database was used to estimate NMSC-related office visits for 2012.

94 een promotion of tegaserod and the number of office visits for abdominal pain, constipation, and bloa

95 % of emergency department visits, and 15% of office visits for acute respiratory infections from Nove

96 Office visits for colds, upper respiratory tract infecti

97 ge, 1.7 to 13.8) of care provided outside of office visits for every 30 minutes of time spent schedul

98 he rate of emergency department or urgent in-office visits for heart failure, arrhythmias, or ICD-rel

99 ey, the authors identified 1,610 psychiatric office visits for patients who smoke.

100 ble amount of time providing care outside of office visits for patients with chronic illness.

101 A nationally representative sample of office visits from the 1989 to 1996 National Ambulatory

102 months, HM only was used but was followed by office visits if necessary.

103 The average duration of office visits in 1989 was 16.3 minutes according to the

104 of unilateral and bilateral studies per 100 office visits in each setting.

105 of life were assessed prospectively for all office visits (IndC = 230; UC = 5388) using previously r

106 with chronic illness require care outside of office visits, much of which is not reimbursed under cur

107 9) completing patient record forms for adult office visits (n=28787).

108 mean cost of acne medications prescribed per office visit nationally and at an academic medical cente

109 An estimated 1.12 billion adult office visits occurred in 1991 and 1992 (95% confidence

110 nue loss of $126,000, increased revenue from office visits of $34,449 to $106,271 (minimum and maximu

111 For concordance between questions and office visits only, 2010 questions (58.08%; 95% CI, 56.4

112 Conventional patients were evaluated with office visits only.

113 ystitis in women can be diagnosed without an office visit or urine culture.

114 of conditions seen in practice during either office visits or hospital stays for each of 186 conditio

115 I, 2.40 to 3.55), and more frequent oncology office visits (OR, 3.14; 95% CI, 2.49 to 3.96).

116 ponsored trial involving 20 subjects with 17 office visits, or approximately 200 hours per subject.

117 We used physician office visit, outpatient department visit, and emergency

118 main utilization outcomes measured included office visits, outpatient surgeries, hospital admissions

119 Including all types of office visits, price indexes at the 90th-percentile HHI

120 Direct (hospitalizations, office visits, procedures, and drug utilization) and ind

121 Direct (hospitalizations, office visits, procedures, and medications) and indirect

122 significant association between EHR use and office visit rates.

123 ns in ED visits and hospitalizations but not office visit rates.

124 dules, and estimates of potential additional office visit revenue comparing immediate sequential cata

125 Independent of the office visit schedule, the interval for monitoring patie

126 MAIN OUTCOME MEASURES: Rates of office visits, telephone encounters, after-hours clinic

127 erly patients, RSV infection generated fewer office visits than influenza; however, the use of health

128 l examinations was 2.21 times higher per 100 office visits than the rate of radiologist-referred bila

129 lar trial eliminates the need for additional office visits to confirm the therapeutic effect.

130 and short counseling sessions during medical office visits to learn about osteoporosis.

131 racial disparities exist in the duration of office visits to psychiatrists is not known.

132 ovided during an estimated 547 million adult office visits to US physicians in 1995, including blood

133 care was associated with similar numbers of office visits, urgent care or emergency department visit

134 events (ED visits and hospitalizations) and office visit use among patients with diabetes, using mul

135 total amount of downstream income from these office visits was 363,813 US dollars (47,386 US dollars

136 icipants in clinical interactions outside of office visits was collected on a structured form.

137 atients with angle-closure glaucoma, whereas office visits was the highest cost category among the "o

138 Using a national survey of office visits, we evaluated differences in the propensit

139 A total of 531 pediatric office visits were recorded that included a principal di

140 ore than 1,800 dollars per survivor; medical office visits were the major component of costs.

141 Consultations and office visits were used to assess nonsurgical care, whil

142 und that medical treatment involved two more office visits, whereas surgical treatment could be more

143 ncreased far more rapidly than the volume of office visits, which benefits specialists who perform th

144 ma subspecialty practice for a nonprocedural office visit who consented to direct observation and 273

145 3 months of clinical follow-up, including an office visit with ECG every week or in cases of symptom

146 d electronic medical records to identify all office visits with an HZ diagnosis for children aged <18

147 h specialty by private PPOs for intermediate office visits with established patients (Current Procedu

148 e county-weighted mean price for 10 types of office visits with new and established patients (CPT cod

149 toring System (SMS) to examine the length of office visits with physicians from 1989 through 1998.

150 d the prevalence of preoperative testing and office visits with the mean percentage of beneficiaries

151 soft tissue sarcomas, patient education and office visits with thorough history and physical examina

152 eted records for >/=5 patients scheduled for office visits within 3 weeks for anti-VEGF injection or

153 Return office visits (within 30 days of the incident visit) for